Crescent Biopharma, Inc. Common Stock (CBIO)

• Market cap: $839M
• 1 day: -2.03%
• 5 days: -19.25%
• 1 month: -49.96%
• 3 months: -52.01%
• 6 months: -41.42%
• Year to date: -49.08%
• 1 year: -46.28%
• 5 years: -95.70%
• 10 years: -98.32%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.58% more ownership

Funds ownership: 47.07% [Q4 2024] → 47.66% (+0.58%) [Q1 2025]

15% less capital invested

Capital invested by funds: $7.56M [Q4 2024] → $6.46M (-$1.1M) [Q1 2025]

17% less funds holding

Funds holding: 41 [Q4 2024] → 34 (-7) [Q1 2025]

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

54% less call options, than puts

Call options by funds: $24K | Put options by funds: $52K

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $22 69% upside
• Avg. target: $22 69% upside
• High target: $22 69% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

LifeSci Capital Charles Zhu

69% upside $22

Outperform Initiated

18 Jun 2025